10 results
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
plant. The proteasome degrades poly-ubiquitinated proteins into their component amino acids, and these amino acids can then be recycled to form new
ARS
2023 FY
CCCC
C4 Therapeutics Inc
28 Apr 23
Annual report to shareholders
7:03am
amino acids, and these amino acids can then be recycled to form new proteins or can be excreted by the cell. This process is illustrated
10-K
2020 FY
CCCC
C4 Therapeutics Inc
11 Mar 21
Annual report
4:19pm
can then be recycled to form new proteins or can be excreted by the cell. This process is illustrated in the following graphic.
Approximately five
8-K
EX-99.1
607qo8 sbxczww18
19 Nov 20
Regulation FD Disclosure
5:00pm
424B4
pw0q nrzj
2 Oct 20
Prospectus supplement with pricing info
5:10pm
S-1/A
1mkxamo9gr8mjcqd
28 Sep 20
IPO registration (amended)
6:07am
S-1
t0y z6c3a20uwajmtc
10 Sep 20
IPO registration
5:26pm
DRS
0hkd0wtb
6 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next